Provider
Atlanta-based Sharecare, the health and wellness engagement platform founded by WebMD founder Jeff Arnold and television personality Dr.
Minneapolis-based Novu has raised $20 million from SSM Partners and Noro-Moseley Partners for its app-enabled wellness program, which it offers to payors, providers, and employers.
Quanttus's original research device.
Brigham and Women's Hospital in Boston will pilot iGetBetter's apps to reduce hospital readmissions through remote patient monitoring and post-discharge patient engagement.
John Brownstein's Computational Epidemiology Group at Boston Children’s Hospital has received attention in the past for its efforts to use data streams from social media, along with publicly available data from the government, to predict outbreaks of disease.
Sense4Baby, the maternal and fetal monitoring product developed by West Health and then acquired by AirStrip Technologies, has received a second FDA 510(k) clearance, which will allow pregnant mothers to perform non-stress tests in their homes.
LifeMap Solutions, the San Jose, California-based company that recently collaborated with Apple on one of the flagship apps for Apple ResearchKit, has launched a new pilot with Mount Sinai Hospital in New York.
A new survey conducted by voice recognition software company Nuance Communications shows that patients don't have a problem with their doctors using technology during visits, as long as technology doesn't get in the way of a meaningful interaction with their physician.
Israel-based Voyant Health, a subsidiary of Germany-based medical technology company Brainlab, received FDA clearance for its iPad app, called TraumaCad Mobile, which helps orthopedic surgeons with their pre-operative surgical planning.
New York City and London-based myHealthPal, not to be confused with telehealth product HealthPAL, data platform MyFitnessPal, or Advocate Children's Hospital's app MyHealth Pal, has raised $744,000 (500,000 pounds) in a round led by Andrew MacKay (chairman of Yapp Brothers) and angel investor Will Armitage with participation from Proxy Ventures.